> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hospira Recalls Vancomycin Lot Due to Particulate Matter
- URL: https://www.fdaweb.com/hospira-recalls-vancomycin-lot-due-to-particulate-matter/
- Published: 2017-01-25T12:00:00.000Z
- Updated: 2026-09-14T22:03:01.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5137815

Hospira has recalled one lot of vancomycin hydrochloride for injection due to a confirmed customer report of particulate matter within a single vial. “In the unlikely event that the particulate is administered to a patient, it may result in local swelling, irritation of blood vessels or tissue, blockage of blood vessels and/or low-level allergic response to the particulate,” a [recall notice](http://www.fda.gov/Safety/Recalls/ucm538214.htm?source=govdelivery&utm%5Fmedium=email&utm%5Fsource=govdelivery) says. To date, the company has not received reports of any adverse events associated with particulate matter for this lot. Vancomycin hydrochloride is indicated for treating serious or severe infections caused by susceptible strains of methicillin-resistant staphylococci.